Renovaro Biosciences Denmark ApS

CVR 26027322 · Private limited company (ApS) · Active · Medium risk

Renovaro Biosciences Denmark ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.9% over the next 12 months, which is 1.3 times the average for Danish companies. 20 annual reports have been published, of which 4 more than six months after the end of the financial year. The latest annual report (30 Jun 2026) shows equity of DKK -91.9m and a net result of DKK -1.2m. CEO: David Hershel Weinstein.

Bankruptcy risk for Renovaro Biosciences Denmark ApS

1.9%
probability of bankruptcy within 12 months
Medium risk

1.3 × the average (1.41%) · higher risk than 82% of active Danish companies

Lowest riskHighest risk

Increases the risk

Qualification / emphasis of matterYes · bankruptcy rate 29.3%3.3×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Municipality changes3+ · bankruptcy rate 10.6%1.2×

Reduces the risk

Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
26027322
Status
Active
Company type
Private limited company (ApS)
Founded
(25 years)
Address
Stumpedyssevej 17
2970 Hørsholm
Municipality
Hørsholm
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 4.0m
Employees
1 (2017)
Auditor
CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB
Audit opted out
No

Warning signs

Annual reports filed late4 of 25
Missing annual reportNo
Negative equityYes
Equity ratio–
Current ratio0%
Moves (last 2 years)0
CEO changes in total4
CEO's previous bankruptcies0
Other companies at the address33
Going-concern uncertaintyYes

Financials and key figures

Financial year20262025
Gross profitDKK -4,478DKK -4,596
Net profitDKK -1.2mDKK -4.6m
EquityDKK -91.9mDKK -90.8m
Total assetsDKK 0DKK 13k
CashDKK 0–
Short-term debtDKK 91.9m–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Crowe.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jul 2025 – 30 Jun 202657
1 Jul 2024 – 30 Jun 2025211 Late
1 Jul 2023 – 30 Jun 2024217 Late
1 Jul 2022 – 30 Jun 2023166
1 Jul 2021 – 30 Jun 2022102
1 Jul 2020 – 30 Jun 202164
1 Jul 2019 – 30 Jun 202098
1 Jul 2018 – 30 Jun 2019129
1 Jul 2017 – 30 Jun 2018153
1 Jan 2016 – 31 Dec 2016152
1 Jan 2015 – 31 Dec 2015190 Late
1 Jan 2014 – 31 Dec 2014140
1 Jan 2013 – 31 Dec 2013163
1 Jan 2012 – 31 Dec 2012171
1 Jan 2011 – 31 Dec 201164
1 Jan 2010 – 31 Dec 2010174
1 Jan 2009 – 31 Dec 2009189 Late
1 Jan 2008 – 31 Dec 2008160
1 Jan 2007 – 31 Dec 2007143
1 Jan 2006 – 31 Dec 2006156

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEODavid Hershel WeinsteinCurrent
CEOPeter Andreas Stakemann
CEOSuzanne Flagstad
BoardKim Madsen
BoardPeter Andreas Stakemann
BoardAnnemette Heller
BoardSteen Lindkær-Jensen
BoardMogens Trygve Lied Flagstad
BoardSteen Sindet-Pedersen
BoardMogens Helweg Claesson
BoardJohn René Frederiksen
BoardHenrik Irgang Elsner
BoardMogens Trygve Lied Flagstad
BoardSuzanne Flagstad
BoardMogens Helweg Claesson
BoardAngela Rossetti
BoardKaare Fiala
BoardUlrik Finnemann
BoardJacob Rosenberg
BoardJesper Zeuthen
BoardDina Asmussen
BoardEric Jean Marie Leire
BoardJacob Rosenberg
BoardPaul Laursen
BoardPeter Brincker Møller
BoardJacob Rosenberg
BoardKnud Carsten Bernhard Lønfeldt
BoardPeter Buhl
BoardSune Olsen
BoardM.R. Tongtis Tongyai
BoardNiels Erik Nielsen
BoardJacob Rosenberg
BoardAldo Michael Noes Petersen
BoardHenrik Grønfeldt-Sørensen
BoardTorben Bjørn Christensen
BoardEric Jean Marie Leire
Owner (100%)Lunai Bioworks Inc.Current
AuditorCROWE STATSAUTORISERET REVISIONSINTERESSENTSKABCurrent
AuditorERNST & YOUNG DENMARK P/S
AuditorKPMG DANMARK A/S
AuditorKristian Henning Pryds
AuditorJannik Hansen Revision v/Jannik Hansen , Statsaut.Revisor
AuditorBAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB
AuditorERNST & YOUNG DENMARK P/S
AuditorBAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB
AuditorBeierholm Godkendt Revisionspartnerselskab
AuditorCROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB
AuditorSDR2 Finance & Consult
AuditorREVISION SJÆLLAND GODKENDT REVISIONSAKTIESELSKAB
FounderVX 10.312 ApSCurrent

The CEOs' other companies

Peter Andreas Stakemann – 54 other companies, of which 54 bankrupt

Suzanne Flagstad – 37 other companies, of which 8 bankrupt

Address history (7 moves)

Stumpedyssevej 17, 2970 Hørsholm
c/o Symbion Science Park, Fruebjergvej 3, 2100 København Ø
c/o Lett Advokatfirma, Rådhuspladsen 4, 1550 København V
Høffdingsvej 34, 2500 Valby
c/o Symbion Science Park, Fruebjergvej 3, 2100 København Ø
c/o Hørsholm Sygehus, Usserød Kongevej 102, 2970 Hørsholm
Kalvebod Brygge 39, 1560 København V
c/o Advokatfiramet Stakemann, Kronprinsessegade 18, 1306 København K

Former names

Renovaro Biosciences Denmark ApS – now
Enochian BioSciences Denmark ApS –
DanDrit Biotech ApS –
DANDRIT BIOTECH A/S –
A/S PSE NR. 5697 –

Employees per year

Number of employees at Renovaro Biosciences Denmark ApS per year482009: 820092011: 020112012: 220122013: 020132014: 120142015: 220152016: 220162017: 12017

Other companies at the same address

Similar companies in Hørsholm

Questions and answers about Renovaro Biosciences Denmark ApS

Has Renovaro Biosciences Denmark ApS gone bankrupt?

No, Renovaro Biosciences Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Renovaro Biosciences Denmark ApS?

Our model estimates a bankruptcy risk of 1.9% over the next 12 months (medium risk), which is 1.3 times the average for Danish companies.

Who is the CEO of Renovaro Biosciences Denmark ApS?

David Hershel Weinstein is the CEO of Renovaro Biosciences Denmark ApS.

Who is the auditor of Renovaro Biosciences Denmark ApS?

Renovaro Biosciences Denmark ApS most recently used CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB.

When was Renovaro Biosciences Denmark ApS founded?

Renovaro Biosciences Denmark ApS was founded on 1 April 2001.

What is the equity of Renovaro Biosciences Denmark ApS?

Equity was DKK -91.9m according to the annual report for the period ending 30 June 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.